Registration Now Open for BOS Events 2024!

Bio2Business Ltd is delighted to open registration for BOS Events 2024 which includes: BOS Basel 2024, which will take place on the 19th and 20th of June at Congress Centre Basel; and BOS Manchester 2024, which will take place on the 26th and 27th of November at Manchester Central.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for virtual events during 2024. We look forward to welcoming you and your colleagues to BOS Events 2024! Please contact the Bio2Business team for further details.

Follow us on LinkedIn to see our latest announcements


Featured Company (BOS Basel 2023)

Logo for Aarti Pharmalabs Limited
Aarti Pharmalabs Limited
Aarti Pharmalabs Limited is a publicly traded company which has 20+ years of experience and has grown up into a multimillion dollar company with 2000+ employees that makes small molecule active pharmaceutical ingredients (APIs), new chemical entities (NCEs), regulatory starting materials (RSMs) and late-stage...
View profile

Featured Speaker (BOS Basel 2023)

photo of Dr Dr Daniel Rixson

Utilisation of Crystallisation Kinetics to Preferentially Isolate a Meta-Stable Form – Pyrimethanil 3-Nitrobenzoic Acid Salt as a Case Study

Dr Daniel Rixson, Scientist II, Veranova

ABSTRACT: The number of Active Parametrical Ingredients (API) or Agrochemicals with less-than-ideal physiochemical properties, such as poor solubility, dissolution and physical / chemical stability has increased over the last decade. The solid form strongly influences these properties, and it is vitally important to understand and manufacture the appropriate solid form. Salts and co-crystals have been identified as viable solid forms that may improve the aforementioned properties of development candidates.

Pyrimethanil, a broad-spectrum fungicide, is able to form both a salt and co-crystal... Click here to Read More